Fetal Health Locus of Control, Maternal Anxiety, and Cardiotocography in High-Risk Pregnancies

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorIstanbul Training and Research Hospital

About this trial

This prospective observational cross-sectional study aims to evaluate the relationships among fetal health locus of control (FHLC) perceptions, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnant women. Pregnant women at 32 weeks of gestation or later who undergo routine non-stress testing (NST) at the Perinatology Outpatient Clinic will be invited to participate. On the same day as the routine NST, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory. Associations between FHLC dimensions, maternal anxiety levels, and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Singleton pregnancy at 32 weeks of gestation or later

Being followed for a high-risk pregnancy

No known diagnosed psychiatric disorder and no current psychiatric medication use

Absence of a fetal condition considered likely to affect the NST tracing

Disqualifiers

Gestational age below 32 weeks and/or multiple pregnancy

Presence of a fetal condition considered likely to affect the NST tracing

Acute maternal infection or an obstetric emergency

Known diagnosed psychiatric disorder and/or current psychiatric medication use

Trial population

Pregnant women at 32 weeks of gestation or later who are being followed for a high-risk pregnancy and undergo routine non-stress testing. Participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as their routine NST.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

150 Participants
are grouped into 1 trial group
Group A: High-Risk Pregnant Women

Trial outcomes

Primary outcomes

1

Association Between Fetal Health Locus of Control and Maternal Anxiety

The relationship between scores obtained from the Fetal Health Locus of Control Scale and maternal anxiety measured using the Beck Anxiety Inventory will be evaluated. The Internal Health Locus of Control, Chance Health Locus of Control, and Powerful Others Health Locus of Control dimensions will be analyzed separately.

Time frame
At the single study visit, on the same day as the routine NST
2

Association Between Fetal Health Locus of Control and Cardiotocography Parameters

Associations between fetal health locus of control dimensions and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Time frame
During the 20-minute routine NST performed at the single study visit
3

Association Between Maternal Anxiety and Cardiotocography Parameters

The relationship between maternal anxiety measured using the Beck Anxiety Inventory and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Time frame
During the 20-minute routine NST performed at the single study visit

Secondary outcomes

1

Associations With Sociodemographic and Obstetric Characteristics

Associations of fetal health locus of control, maternal anxiety levels, and cardiotocography parameters with maternal sociodemographic and obstetric characteristics, including age, gravidity, education level, income level, consanguinity, smoking status, and pre-pregnancy preparation, will be evaluated.

Time frame
At the single study visit

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.